What are the best medications for treating anxiety and obsessive-compulsive disorder (OCD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Best Medications for Anxiety and OCD

For anxiety and OCD, SSRIs are the first-line pharmacological treatment, with sertraline being the preferred option due to its favorable side effect profile, low potential for drug interactions, and established efficacy. 1

First-Line Medications

For Anxiety Disorders:

  • SSRIs (Selective Serotonin Reuptake Inhibitors)
    • Sertraline: 50-200 mg daily, FDA-approved for panic disorder and PTSD 2
    • Escitalopram: 10-20 mg daily, good option if sertraline is not tolerated 1
    • Fluoxetine: 20-60 mg daily, FDA-approved for panic disorder 3

For OCD:

  • SSRIs at higher doses than used for anxiety or depression 4
    • Sertraline: 50-200 mg daily, FDA-approved for OCD 2
    • Fluoxetine: 40-60 mg daily, FDA-approved for OCD 3, 5
    • Optimal dose for OCD appears to be around 40 mg fluoxetine equivalent 6

Treatment Algorithm

  1. Initial Treatment:

    • Start with an SSRI (preferably sertraline) at a low dose
    • For anxiety: Begin with sertraline 25-50 mg daily
    • For OCD: Begin with sertraline 50 mg daily, with plan to increase 4
  2. Dose Titration:

    • For anxiety: Increase dose as tolerated at 1-2 week intervals for shorter half-life SSRIs (sertraline) or 3-4 week intervals for longer half-life SSRIs (fluoxetine) 4
    • For OCD: Higher doses are typically required; increase gradually to minimize side effects 4
    • Target dose for OCD: Sertraline 200 mg or fluoxetine 40-60 mg 4, 5
  3. Duration of Trial:

    • Allow 8-12 weeks to determine efficacy for OCD 4
    • Early improvement (within 2-4 weeks) may predict treatment response 4
  4. Maintenance Treatment:

    • Continue medication for at least 12-24 months after achieving remission 4, 1
    • Longer treatment may be necessary due to high risk of relapse 4

Treatment-Resistant Cases

If inadequate response to first-line SSRI treatment:

  1. Switch to another SSRI 4
  2. Consider clomipramine: Effective for OCD but has more side effects than SSRIs 4, 7
    • Dosage: Gradually titrate to 150-250 mg/day 7
    • Monitor for anticholinergic side effects and potential cardiac issues 4
  3. Augmentation strategies:
    • Add antipsychotics (risperidone or aripiprazole have the strongest evidence) 4
    • Consider glutamatergic agents 4
    • Combine with CBT (most effective augmentation strategy) 4, 8

Important Considerations

  • Side Effects:

    • SSRIs: Initial gastrointestinal symptoms, sexual dysfunction, potential for discontinuation syndrome with paroxetine, fluvoxamine, and sertraline 4
    • Clomipramine: More anticholinergic effects, cardiotoxicity concerns, and greater risk with overdose 4, 5
  • Monitoring:

    • Assess response at 2,4,6, and 12 weeks using standardized rating scales 1
    • Monitor for suicidal thinking, especially in patients under 24 years 4, 1
  • Discontinuation:

    • Taper gradually to avoid discontinuation syndrome, especially with shorter-acting SSRIs 1
    • Plan for at least 12-24 months of treatment before considering discontinuation 4

Special Considerations for OCD

  • OCD often requires higher SSRI doses than those used for depression or anxiety disorders 4
  • Response may be slower in OCD compared to depression, requiring patience with the treatment regimen 4, 9
  • Combination of medication with cognitive-behavioral therapy (particularly exposure and response prevention) provides superior outcomes 4, 8

Pitfalls to Avoid

  • Underdosing: OCD typically requires higher SSRI doses than depression or anxiety 4
  • Premature discontinuation: Evaluate efficacy after adequate duration (8-12 weeks) 4
  • Ignoring drug interactions: Particularly with fluvoxamine and citalopram 4
  • Abrupt discontinuation: Can lead to withdrawal symptoms, especially with shorter-acting SSRIs 4, 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.